13F HOLDINGS REPORT
Qiming U.S. Ventures Management, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001415889-25-021900
Total Value
$23.6M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TOURMALINE BIO INC | 89157D105 | 741,691 | $11.9M | 50.22% |
| 2 | JASPER THERAPEUTICS INC | JSPRW | 928,964 | $5.2M | 21.83% |
| 3 | KORRO BIO INC | KRRO | 368,085 | $4.6M | 19.47% |
| 4 | VENTYX BIOSCIENCES INC | 92332V107 | 412,225 | $882,162 | 3.74% |
| 5 | HILLEVAX INC | 43157M102 | 372,615 | $741,504 | 3.14% |
| 6 | KEZAR LIFE SCIENCES INC | KZR | 82,871 | $379,549 | 1.61% |